A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 251 participants.

Also called NCT07340320

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 251 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT07340320
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Poland (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT07340320. Randomized; double masking; primary purpose treatment. Start 2026-02-06 (actual); primary completion 2027-04-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Condition
Type II Diabetes Mellitus
Intervention (Drug)
CX11
Intervention (Other)
Placebo
Lead sponsor
Corxel Pharmaceuticals (class: industry)

Record details

Record id
cardio:ct-nct07340320
Content hash
d5b2ce603a98c5bd58a6b658dd1af799bfac9b00c597d78c2f154847b1f06988